Summit Tx Capital, L.P. Grifols Sa Transaction History
Summit Tx Capital, L.P.
- $2.42 Trillion
- Q3 2025
A detailed history of Summit Tx Capital, L.P. transactions in Grifols Sa stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 30,256 shares of GRFS stock, worth $263,529. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,256
Previous 116,679
74.07%
Holding current value
$263,529
Previous $1.05 Billion
71.43%
% of portfolio
0.01%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding GRFS
# of Institutions
200Shares Held
148MCall Options Held
76.1KPut Options Held
58.2K-
Brandes Investment Partners, LP La Jolla, CA29.1MShares$254 Million2.44% of portfolio
-
Capital World Investors Los Angeles, CA22.9MShares$200 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY17.5MShares$152 Million27.86% of portfolio
-
Black Creek Investment Management Inc. Toronto, A610MShares$87.5 Million5.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.94MShares$60.4 Million0.03% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.91B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...